REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $884,000 | +84.9% | 32,735 | -5.3% | 0.01% | +100.0% |
| Q2 2022 | $478,000 | -33.4% | 34,558 | -6.1% | 0.00% | 0.0% |
| Q1 2022 | $718,000 | +23.2% | 36,805 | +2.9% | 0.00% | +33.3% |
| Q4 2021 | $583,000 | -41.2% | 35,762 | +0.4% | 0.00% | -50.0% |
| Q3 2021 | $992,000 | -8.1% | 35,604 | -2.3% | 0.01% | 0.0% |
| Q2 2021 | $1,080,000 | +11.1% | 36,431 | +4.8% | 0.01% | 0.0% |
| Q1 2021 | $972,000 | +88.7% | 34,764 | +91.2% | 0.01% | +100.0% |
| Q4 2020 | $515,000 | – | 18,186 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |